Similar to findings of M2-like CD163+ TAMs, the presence of CD68+ TAMs is associated with poor prognosis in nasopharyngeal carcinoma (NPC), gastric and hepatocellular cancers, this study investigated whether CD68+ TAMs could also be adopted as a prognostic indicator in OSCC. This evidence concerns the gene CD68 and hepatocellular carcinoma.